Literature DB >> 3203033

High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

M Barbir1, D Wile, I Trayner, V R Aber, G R Thompson.   

Abstract

Serum lipids and apolipoproteins A-I and B were measured in 174 men aged less than 60 with angiographically confirmed coronary artery disease and in 572 healthy control men. Two thirds of the patients had raised age-corrected values of fasting serum cholesterol and/or triglyceride and/or a low high density lipoprotein (HDL) cholesterol compared with the controls. Eighteen (30%) of the 61 normolipidaemic patients had a concentration of serum apolipoprotein A-I below the 5th percentile of 233 controls. In normolipidaemic patients on beta blockers the relative prevalence of serum low density lipoprotein (LDL)-apolipoprotein B values above the 95th percentile of 339 controls was significantly increased. Discriminant function analysis showed that a raised concentration of serum triglyceride was the best discriminant between patients and controls, with raised LDL-apolipoprotein B and reduced apolipoprotein A-I coming second only to triglyceride in analyses where each was separately compared with all the lipid variables. These associations were highly significant and were independent of other influences, including beta blockade. These findings re-emphasise the importance of hypertriglyceridaemia as a risk factor and confirm that apolipoprotein abnormalities occur frequently in coronary disease, even in normolipidaemic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3203033      PMCID: PMC1216597          DOI: 10.1136/hrt.60.5.397

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  37 in total

1.  Effect of smoking on serum levels of HDL apoproteins.

Authors:  K Berg; A L Börresen; G Dahlen
Journal:  Atherosclerosis       Date:  1979-11       Impact factor: 5.162

2.  Determination of B protein of low density lipoprotein directly in plasma.

Authors:  A Sniderman; B Teng; M Jerry
Journal:  J Lipid Res       Date:  1975-11       Impact factor: 5.922

3.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

4.  The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease.

Authors:  T Ishikawa; N Fidge; D S Thelle; O H Førde; N E Miller
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population.

Authors:  B Lewis; A Chait; C M Oakley; I D Wootton; D M Krikler; A Onitiri; G Sigurdsson; A February
Journal:  Br Med J       Date:  1974-08-24

7.  Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease.

Authors:  S B Hulley; R H Rosenman; R D Bawol; R J Brand
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

8.  High density lipoprotein and apolipoprotein A-i during physical inactivity. Demonstration at low levels in patients with spine fracture.

Authors:  E A Nikkilä; T Kuusi; P Myllynen
Journal:  Atherosclerosis       Date:  1980-11       Impact factor: 5.162

9.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

10.  Relation of parental history of early myocardial infarction to the level of apoprotein B in men.

Authors:  F Cambien; J M Warnet; A Jacqueson; P Ducimetiere; J L Richard; J R Claude
Journal:  Circulation       Date:  1987-08       Impact factor: 29.690

View more
  16 in total

1.  High density lipoprotein cholesterol and triglycerides as markers of angiographically assessed coronary artery disease.

Authors:  M Nikkilä; T Koivula; K Niemelä; T Sisto
Journal:  Br Heart J       Date:  1990-02

2.  Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery disease.

Authors:  J Iwanejko; M Kwaśniak; I Wybrańska; J Hartwich; I Guevara; A Zdzienicka; O Kruszelnicka-Kwiatkowska; W Piwowarska; B Miszczuk-Jamska; A Dembińska-Kieć
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 3.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

4.  Lipoprotein lipase activity in patients with combined hyperlipidaemia.

Authors:  M Seed; F Mailly; D Vallance; E Doherty; A Winder; P Talmud; S E Humphries
Journal:  Clin Investig       Date:  1994-01

5.  Serum lipid and apolipoprotein distributions in Hong Kong Chinese.

Authors:  P C Fong; S C Tam; Y T Tai; C P Lau; J Lee; Y Y Sha
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

Review 6.  Pharmacological control of hypertriglyceridemia.

Authors:  G Franceschini; R Paoletti
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 7.  Triglyceride-rich lipoproteins and atherosclerosis.

Authors:  P Schwandt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 8.  Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.

Authors:  Allan D Sniderman; Patrick Couture; Seth S Martin; Jacqueline DeGraaf; Patrick R Lawler; William C Cromwell; John T Wilkins; George Thanassoulis
Journal:  J Lipid Res       Date:  2018-05-16       Impact factor: 5.922

Review 9.  Global risk of cardiovascular disease.

Authors:  N Poulter
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

10.  Relationship between smoking and dyslipidemia in western Chinese elderly males.

Authors:  X J Tan; G P Jiao; Y J Ren; X R Gao; Y Ding; X R Wang; H Xu
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.